Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
3.
Oxf Med Case Reports ; 2018(12): omy105, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30487990

RESUMEN

Cabozantinib is a tyrosine kinase inhibitor which is increasingly being used for the treatment of metastatic renal cell cancer. Skin toxicity such as palmar-plantar erythrodysesthesia is not uncommon with such agents. However, bullous skin reactions are not common and we report the case of a patient with metastatic renal cell cancer who experienced such cutaneous toxicity.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...